TY  - JOUR
AU  - Diaz-Alonso, Javier
AU  - Paraiso-Luna, Juan
AU  - Navarrete, Carmen
AU  - Del Rio, Carmen
AU  - Cantarero, Irene
AU  - Palomares, Belen
AU  - Aguareles, Jose
AU  - Fernandez-Ruiz, Javier
AU  - Bellido, Maria Luz
AU  - Pollastro, Federica
AU  - Appendino, Giovanni
AU  - Calzado, Marco A
AU  - Galve-Roperh, Ismael
AU  - Muñoz, Eduardo
PY  - 2016
DO  - 10.1038/srep29789
UR  - http://hdl.handle.net/10668/10280
T2  - Scientific reports
AB  - Cannabinoids have shown to exert neuroprotective actions in animal models by acting at different targets including canonical cannabinoid receptors and PPARγ. We previously showed that VCE-003, a cannabigerol (CBG) quinone derivative, is a novel...
LA  - en
PB  - Nature Publishing Group
KW  - Mesenchymal stem cells
KW  - Mice, inbred C57BL
KW  - Neural stem cells
KW  - Neuroprotective agents
KW  - Quinones
KW  - Rats
KW  - Animals
KW  - Cannabinoids
KW  - Cell differentiation
KW  - Cell line
KW  - Cell line, tumor
KW  - Cell survival
KW  - Cells, cultured
KW  - Disease models, animal
KW  - Gene expression
KW  - HEK293 cells
KW  - Humans
KW  - Huntington disease
KW  - Male
TI  - VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington's disease.
TY  - research article
VL  - 6
ER  -